ArticleMolecular cancer therapeutics2017

Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.

Tessa Humphries-Bickley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.